HL-526 Improved Survival of Elderly Patients with Classical Hodgkin Lymphoma (chl) in the Modern Era - A SEER-Registry Analysis.

In this SEER analysis, we found that elderly cHL patients who were diagnosed with cHL after 2010 had improved survival by about 9 months compared to patients diagnosed before 2010. The improved 5-year overall and lymphoma-specific survival likely reflects improvement in treatment modalities and uptake of targeted agents in elderly population. Lastly, we did not see any difference in survival of NHBs compared to NHWs unlike in previous SEER analysis; however, Hispanic patients had worse OS compared to NHWs.